This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1987 May 15;257(19):2634-6.

Hepatitis B vaccines--to switch or not to switch

PMID: 2952813

Hepatitis B vaccines--to switch or not to switch

F B Hollinger. JAMA. 1987.

. 1987 May 15;257(19):2634-6.

Author

PMID: 2952813

No abstract available

PubMed Disclaimer

Similar articles

Update on hepatitis B prevention.
Centers for Disease Control (CDC). Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep. 1987 Jun 19;36(23):353-60, 366. MMWR Morb Mortal Wkly Rep. 1987. PMID: 2953959 No abstract available.
Leads from the MMWR. Recommendations of the immunization practices advisory committee update on hepatitis B prevention.
[No authors listed] [No authors listed] JAMA. 1987 Jul 24-31;258(4):437, 444-5, 449. JAMA. 1987. PMID: 2955136 No abstract available.
[Hepatitis B vaccination in dialysis patients: reversibility of defective immune response by simultaneous administration of interleukin 2].
Zeitz M. Zeitz M. Z Gastroenterol. 1990 Mar;28(3):179-80. Z Gastroenterol. 1990. PMID: 2140478 German. No abstract available.
Control measures against hepatitis B infection.
Frösner GG, Franco E. Frösner GG, et al. Ann Ist Super Sanita. 1987;24(2):267-75. Ann Ist Super Sanita. 1987. PMID: 2969204 Review. No abstract available.
Hepatitis B vaccines.
Troisi CL, Hollinger FB. Troisi CL, et al. Prog Liver Dis. 1990;9:405-42. Prog Liver Dis. 1990. PMID: 2156306 Review. No abstract available.

See all similar articles

Cited by

Immunogenicity of yeast-derived hepatitis B vaccine from two different producers.
Dahl-Hansen E, Siebke JC, Frøland SS, Degré M. Dahl-Hansen E, et al. Epidemiol Infect. 1990 Feb;104(1):143-9. doi: 10.1017/s0950268800054625. Epidemiol Infect. 1990. PMID: 2137785 Free PMC article.
The cellular basis for lack of antibody response to hepatitis B vaccine in humans.
Egea E, Iglesias A, Salazar M, Morimoto C, Kruskall MS, Awdeh Z, Schlossman SF, Alper CA, Yunis EJ. Egea E, et al. J Exp Med. 1991 Mar 1;173(3):531-8. doi: 10.1084/jem.173.3.531. J Exp Med. 1991. PMID: 1825504 Free PMC article.
A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B.
Honorati MC, Palareti A, Dolzani P, Busachi CA, Rizzoli R, Facchini A. Honorati MC, et al. Clin Exp Immunol. 1999 Apr;116(1):121-6. doi: 10.1046/j.1365-2249.1999.00866.x. Clin Exp Immunol. 1999. PMID: 10209515 Free PMC article.
The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen.
Wismans PJ, van Hattum J, De Gast GC, Endeman HJ, Poel J, Stolk B, Maikoe T, Mudde GC. Wismans PJ, et al. Clin Exp Immunol. 1989 Oct;78(1):75-9. Clin Exp Immunol. 1989. PMID: 2805427 Free PMC article.
Vaccination for hepatitis B.
Tolle SW. Tolle SW. West J Med. 1987 Sep;147(3):326. West J Med. 1987. PMID: 18750319 Free PMC article. No abstract available.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information